Exosome mimetics: a novel class of drug delivery systems
SAA Kooijmans, P Vader… - International journal …, 2012 - Taylor & Francis
The identification of extracellular phospholipid vesicles as conveyors of cellular information
has created excitement in the field of drug delivery. Biological therapeutics, including short …
has created excitement in the field of drug delivery. Biological therapeutics, including short …
Exosomes and exosome-inspired vesicles for targeted drug delivery
SG Antimisiaris, S Mourtas, A Marazioti - Pharmaceutics, 2018 - mdpi.com
The similarities between exosomes and liposomes, together with the high organotropism of
several types of exosomes, have recently prompted the development of engineered …
several types of exosomes, have recently prompted the development of engineered …
Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives
A Butreddy, N Kommineni, N Dudhipala - Nanomaterials, 2021 - mdpi.com
Exosomes as nanosized vesicles are emerging as drug delivery systems for therapeutics
owing to their natural origin, their ability to mediate intercellular communication, and their …
owing to their natural origin, their ability to mediate intercellular communication, and their …
Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges
Exosomes are small nanoparticles secreted by almost all cells and have a well-known role
in intercellular communication. They are found in different body fluids and can also be …
in intercellular communication. They are found in different body fluids and can also be …
[HTML][HTML] Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
D Ha, N Yang, V Nadithe - Acta Pharmaceutica Sinica B, 2016 - Elsevier
Exosomes are small intracellular membrane-based vesicles with different compositions that
are involved in several biological and pathological processes. The exploitation of exosomes …
are involved in several biological and pathological processes. The exploitation of exosomes …
Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity
SW Ferguson, J Nguyen - Journal of Controlled Release, 2016 - Elsevier
Harnessing exosomes as therapeutic drug delivery vehicles requires a better understanding
of exosomal composition and their mode of action. A full appreciation of all the exosomal …
of exosomal composition and their mode of action. A full appreciation of all the exosomal …
Exosome: a significant nano-scale drug delivery carrier
H Peng, W Ji, R Zhao, J Yang, Z Lu, Y Li… - Journal of Materials …, 2020 - pubs.rsc.org
In recent years, due to the limitations of the nature of therapeutic agents, many synthetic
nano-delivery systems have emerged to enhance the efficacy of drugs. Extracellular vesicles …
nano-delivery systems have emerged to enhance the efficacy of drugs. Extracellular vesicles …
Exosomes as new generation vehicles for drug delivery: biomedical applications and future perspectives
A Rajput, A Varshney, R Bajaj, V Pokharkar - Molecules, 2022 - mdpi.com
Currently, particular interest among the scientific community is focused on exploring the use
of exosomes for several pharmaceutical and biomedical applications. This is due to the …
of exosomes for several pharmaceutical and biomedical applications. This is due to the …
Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives
Abstract Exosomes are nanosized (size~ 30–150 nm) natural vesicular structures released
from cells by physiological processes or pathological circumstances. Exosomes are growing …
from cells by physiological processes or pathological circumstances. Exosomes are growing …
Biomimetic exosomes: a new generation of drug delivery system
X Wang, X Zhao, Y Zhong, J Shen… - Frontiers in bioengineering …, 2022 - frontiersin.org
Most of the naked drugs, including small molecules, inorganic agents, and
biomacromolecule agents, cannot be used directly for disease treatment because of their …
biomacromolecule agents, cannot be used directly for disease treatment because of their …